Dr. Carol Laherty focuses her practice on formulating and executing patent and market exclusivity strategies consistent with biotechnology and pharmaceutical companies’ business goals. She has extensive experience in strategic patent counseling and patent portfolio management, preparation and worldwide prosecution of patent applications, intellectual property due diligence, freedom to operate analyses and legal opinions. In addition, Carol counsels investors and companies with respect to intellectual property issues related to potential investments, acquisitions and licensing and partnering opportunities.
Carol has experience in a wide range of technologies, including cellular and molecular biology, immunology, polypeptide and polynucleotide therapeutics, therapeutic antibodies, recombinant vaccines, gene therapy, stem cell therapeutics, diagnostics, drug formulations, drug delivery systems and cleantech biotechnologies.